SCHEMBL9280943

SCHEMBL9280943

CCOC(=O)C1(N)C2CCC1C(c1nsnc1Cl)=C(Cl)C2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2383228 0.57 MAPT (0.60)
SCHEMBL3637470 0.57 CYP3A4 (0.47)
SCHEMBL4553774 0.56 KDM4E (0.56)
SCHEMBL13011189 0.55 ALDH1A1 (0.36)
SCHEMBL28153565 0.54 POLB (0.36)
SCHEMBL372547 0.54
Hydrochloric Acid SCHEMBL20447769 0.53 ALOX15 (0.42)
SCHEMBL22441532 0.53
Hydrochloric Acid SCHEMBL741807 0.53 ALOX15 (0.42)
SCHEMBL7386383 0.52 LMNA (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0735869-A1 A METHOD OF TREATING GASTROINTESTINAL MOTILITY DISORDERS NOVO NORDISK A/S (DK) 1996-10-09 EP disclosed
EP-0714394-A1 ANTIPSYCHOTIC METHOD NOVO NORDISK A/S (DK) 1996-06-05 EP disclosed
WO-1995017180-A1 A METHOD OF TREATING GASTROINTESTINAL MOTILITY DISORDERS NOVO NORDISK A/S (DK) 1995-06-29 WO disclosed
WO-1995005379-A1 ANTIPSYCHOTIC METHOD NOVO NORDISK A/S (DK) 1995-02-23 WO disclosed